About Us
Science
- Overview
- Pipeline
News & Events
Menu Menu

Fusion conference: Targeting the DNA Damage Response for Cancer

3 July 2025

Fusion conference: Targeting the DNA Damage Response for Cancer
Lisbon, Portugal
29 June-02 July 2025

https://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svg 0 0 dSpeidel https://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svg dSpeidel2025-07-03 12:36:582025-04-02 12:37:10Fusion conference: Targeting the DNA Damage Response for Cancer

MODULATING DNA DAMAGE RESPONSES TO CURE CANCER

Contact Us

Breakpoint Therapeutics GmbH
Essener Bogen 7
22419 Hamburg (Germany)

Telefon: +49 40 56081 180
E-mail: info@breakpointtx.com

Impressum

Registergericht: Hamburg
Registernummer: HRB 155717
Umsatzsteuer-Identifikationsnummer: DE 324 797 830

Geschäftsführer / Managing Directors
Dr. Daniel Speidel and Jonathan Hollick

Links

Privacy Statement

Breakpoint Therapeutics GmbH @ Website by FisherPaul

Privacy Statement

BIO International Convention 2025